STACI DAMIANI: Open Payments
NPI 1043753502 · TRENTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,275 in 128 payments from 28 companies in 2025. Trend: 2023 $1,790 · 2024 $2,319 · 2025 $2,275
Food & beverage: $2,275
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $353 |
| AstraZeneca Pharmaceuticals LP | 11 | $302 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $219 |
| PFIZER INC. | 11 | $201 |
| ABBVIE INC. | 12 | $189 |
| Otsuka America Pharmaceutical, Inc. | 11 | $161 |
| Lilly USA, LLC | 14 | $144 |
| GlaxoSmithKline, LLC. | 5 | $84 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| Exact Sciences Corporation | 4 | $72 |
Products named: CAPLYTA, AIRSUPRA, REXULTI, Ozempic, Wegovy, MOUNJARO, VRAYLAR, ELIQUIS.
Industry payments across MI — which companies pay providers there.
